The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Naraverg 2.5 mg Film-coated Tablets



Teva Pharma B.V.PA0749/065/001

Main Information

Trade NameNaraverg 2.5 mg Film-coated Tablets
Active SubstancesNaratriptan
Dosage FormFilm-coated tablet
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/065/001

Group Information

ATC CodeN02CC Selective serotonin (5HT1) agonists
N02CC02 naratriptan

Status

License statusAuthorised
Licence Issued16/05/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back